PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-55

  1. Svall
    84 Posts.
    lightbulb Created with Sketch. 42
    clock Created with Sketch.
    24/08/20
    13:43
    Post #: 46768928
    Why has it stayed like this? Is it scientific risk or just management have been slow?

    ANP Price at posting: 10.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
LU7 Filling the Lithium Conversion Gap: Lithium Universe commits to community collaboration through formation of joint committee for Bécancour
right-arrow Created with Sketch.
NEWS Want to talk crypto? Click here to join the discussion!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $11.14K 139.3K

Buyers (Bids)

No. Vol. Price($)
2 122542 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 93141 3
View Market Depth
Last trade - 14.21pm 22/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.